Key Highlights
-
Purity: >98% (HPLC Tested)
-
Form: Lyophilised Powder
-
Packaging: Sterile 2ml Vial
-
Intended Use: Laboratory research use only – not for human consumption.
-
Storage: Store below 25°C, away from light and moisture.
Product Overview
Tirzepatide is a novel dual-acting peptide that functions as both a GLP-1 (glucagon-like peptide-1) receptor agonist and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist. In research, it has shown potential in blood glucose regulation, weight management, and metabolic health studies.
Its unique dual mechanism may improve insulin sensitivity, reduce appetite, and enhance metabolic efficiency, making it a focus for obesity, type 2 diabetes, and cardiovascular health research.
Potential Applications (Research Only)
-
Studies on obesity and weight regulation.
-
Research into type 2 diabetes and insulin resistance.
-
Appetite suppression and satiety regulation research.
-
Investigations into cardiovascular and metabolic health.
Disclaimer: For laboratory research purposes only. Not for human or veterinary use.
Storage & Handling
-
Store lyophilised powder below 25°C.
-
Protect from light and moisture.
-
Once reconstituted, refrigerate at 2–8°C.
-
Avoid repeated freeze–thaw cycles.
Solubility & Stability
-
Soluble in bacteriostatic water or sterile saline under lab conditions.
-
Stability dependent on temperature, pH, and light exposure.
Trust & Legitimacy
-
COA available for every batch.
-
HPLC and Mass Spectrometry tested for purity and identity.
-
Supplied exclusively for research use.
Specifications
Attribute |
Detail |
CAS Number |
2023788-19-2 |
Purity |
>98% (HPLC) |
Appearance |
White Lyophilised Powder |
Molecular Formula |
C225H348N48O68 |
Molecular Weight |
4813.5 g/mol |
Form |
Lyophilised Powder |
Packaging |
Sterile 2ml Vial |